Drawing for ADPROTECH

USPTO serial 76183783

ADPROTECH

Reviewed by CopyMark Law Group

Reg. 2863973Status 710
Filing date
Status date
Registration date
Jul 20, 2004
Examiner
SOUDERS, MICHAEL J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ADPROTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN C WILSON

JOHN C WILSON HELLER EHRMAN WHITE & MCAULIFFE LLP333 BUSH STSAN FRANCISCO, CA 94104-2878UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, protein therapeutic agents, prodrugs and polypeptides for the treatment of cardiovascular system diseases, autoimmune and inflammatory disorders, infectious diseases, neurological disorders, post-ischemic reperfusion conditions and cancer, and in organ transplantation; veterinary preparations, protein therapeutic agents, prodrugs and ploypeptides for the treatment of cardiovascular system diseases, autoimmune and inflammatory disorders, infectious diseases, neurological disorders, post-ischemic reperfusion conditions and cancer, and in organ transplantation, for use in domestic animals and livestock; immunotherapeutic agents for the treatment of autoimmune and inflammatory disorders, infectious diseases and cancer, for use in humans and domestic animals and livestock; vaccine molecular adjuvantsSECTION 8 - CANCELLED—
010Medical and veterinary apparatus and instruments, namely, depot devices for the delivery of drugs and vaccine adjuvants, syringes, and catheters; drug delivery systems consisting primarily of implant devices for the delivery of drugs and vaccine adjuvants, depot devices for the delivery of drugs and vaccine adjuvants, syringes, catheters, and vaccine adjuvantsSECTION 8 - CANCELLED—
042Biotechnology product research and development; product development for others in the chemical, medical and veterinary fields; product research and development relating to modification of pharmaceutically useful molecules, protein therapeutic agents, immunotherapeutic agents, prodrugs, polypeptides or molecular adjuvants; technical consultation services relating to biotechnology, modification of pharmaceutically useful molecules, protein therapeutic agents, immunotherapeutic agents, prodrugs, polypeptides or molecular adjuvantsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 25, 2011C8..CANCELLED SEC. 8 (6-YR)—
Jul 20, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2004IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 3, 2004EX1GSOU EXTENSION 1 GRANTED—
May 28, 2004CFITCASE FILE IN TICRS—
May 26, 20041.BDSec. 1(B) CLAIM DELETED—
May 26, 2004MAILPAPER RECEIVED—
May 24, 2004EXT1SOU EXTENSION 1 FILED—
May 24, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 2, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 13, 2003NPUBNOTICE OF PUBLICATION—
Jun 13, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2003CNEAEXAMINERS AMENDMENT MAILED—
Nov 19, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 3, 2002TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 12, 2002MAILPAPER RECEIVED—
Jul 9, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2002CNSLLETTER OF SUSPENSION MAILED—
Oct 16, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance